Last reviewed · How we verify

NCT06260046

Effect of Sufentanil on the Postoperative Pain

Not yet recruiting NA Last updated 15 February 2024
What this trial tests

NA trial testing Sufentanil in Postoperative Pain, Acute in 48 participants. Not yet recruiting.

Timeline
1 March 2024
Primary endpoint
15 January 2025
15 January 2027

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment48
Start date1 March 2024
Primary completion15 January 2025
Estimated completion15 January 2027
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Postoperative Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sufentanil

Trials testing the same drug.

Other recruiting trials for Postoperative Pain, Acute

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06260046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing